Related Experiment Video
Updated: Jan 30, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
A Comprehensive Review of Patient-reported Outcomes in Patients With Chronic Liver Diseases
Zobair M Younossi1,2, Pegah Golabi1,2, Linda Henry2,3
1Department of Medicine, Center for Liver Diseases, Inova Fairfax Hospital.
Insights
Chronic liver disease (CLD) significantly impacts patients
Area of Science:
- Hepatology and Gastroenterology
- Patient-Reported Outcomes Research
- Clinical Epidemiology
Background:
- Chronic liver disease (CLD) presents a substantial global health challenge, contributing significantly to mortality worldwide.
- Beyond clinical manifestations, CLD profoundly affects patients' health-related quality of life and other patient-reported outcomes (PROs).
- Integrating clinical data with PROs offers a comprehensive understanding of the disease burden on patients.
Purpose of the Study:
- To review the assessment of patient-reported outcomes (PROs) in various chronic liver diseases.
- To summarize the available validated tools and questionnaires for measuring PROs in CLD patients.
- To provide a resource for investigators and clinicians interested in the patient experience of liver disease.
Main Methods:
- Literature review of studies assessing patient-reported outcomes in chronic liver disease.
- Identification and categorization of validated questionnaires and tools used for PRO assessment in CLD.
- Synthesis of findings on the application of PROs in understanding the impact of CLD and its treatments.
Main Results:
- Various generic and disease-specific instruments, such as the Short Form-36 and Chronic Liver Disease Questionnaire, are available for PRO assessment.
- PRO instruments are crucial for evaluating the impact of CLD's natural history and treatment interventions on patients' experiences.
- The review highlights the importance of PROs in capturing the comprehensive burden of liver disease.
Conclusions:
- Patient-reported outcomes (PROs) are essential for a holistic assessment of chronic liver disease (CLD) impact.
- Validated tools are available to measure PROs, aiding in understanding patient experiences.
- This review provides a valuable summary of PRO assessment methods for researchers and clinicians in the field of hepatology.
Abstract:
Chronic liver disease (CLD) is a global health problem with chronic viral hepatitis, alcohol-related liver disease, and nonalcoholic fatty liver disease being important causes of mortality. Besides its clinical burden, patients with CLD also suffer from impairment of their health-related quality of life and other patient-reported outcomes (PRO). In this context, a combination of both clinical and PROs will allow assessment of the comprehensive burden of liver disease on patients. PROs cannot be observed directly and must be assessed by validated questionnaires or tools. Various tools have been developed to accurately measure PROs in patients with CLD, including generic and disease-specific questionnaires such as Short Form-36, Chronic Liver Disease Questionnaire and its subtypes. It is important to note that PRO instruments can be used to appreciate the impact of the natural history of CLD or of treatment on patients' experiences. This review summarizes PRO assessment in different types of liver disease and different tools useful to investigators and clinicians who are interested in this aspect of patients' experience.
More Related Videos
03:25Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
Published on: December 27, 2024
07:10Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Patient-centered Care
Data Reporting and Recording
Drug Dosing: Geriatric Patients
Chronic Kidney Disease I: Introduction
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...